Effects of fenofibrate on plasma and hepatic transaminase activities and hepatic transaminase gene expression in rats

Journal of Toxicological Sciences

Volumn 34, Issue 4, 2009, Pages 377-387

  Kobayashi, Akio ^a,b   Suzuki, Yusuke ^a   Kuno, Hideyuki ^a   Sugai, Shoichiro ^a   Sakakibara, Hiroyuki ^b   Shimoi, Kayoko ^b  

^a JAPAN TOBACCO INC   (Japan)

^b UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Alanine aminotransferase; Aspartate aminotransferase; Fenofibrate; Induction; Rats

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHOLESTEROL; FENOFIBRATE; LACTATE DEHYDROGENASE; MESSENGER RNA; TRIACYLGLYCEROL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD; BLOOD CHEMISTRY; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; GENE CONTROL; GENE EXPRESSION; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER; LIVER TOXICITY; LIVER WEIGHT; MALE; NONHUMAN; RAT; SINGLE DRUG DOSE; TRIACYLGLYCEROL BLOOD LEVEL;

RATTUS;

EID: 68549106059     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.34.377     Document Type: Article

References (23)

1. Aggerbeck, M., Garlatti, M., Feilleux-Duché, S., Veyssier, C., Daheshia, M., Hanoune, J. and Barouki, R. (1993): Regulation of the cytosolic aspartate aminotransferase housekeeping gene promoter by glucocorticoids, cAMP, and insulin. Biochemistry, 32, 9065-9072. (Pubitemid 24186227)
2. Balfour, J.A, McTavish, D. and Heel, R.C. (1990): Fenofibrate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in dyslipidaemia. Drugs, 40, 260-290.
3. Barouki, R., Pavé-Preux, M., Bousquet-Lemercier, B., Pol., S., Bouguet, J. and Hanoune, J. (1989): Regulation of cytosolic aspartate aminotransferase mRNAs in the Fao rat hepatoma cell line by dexamethasone, insulin and cyclic AMP. Eur. J. Biochem., 186, 79-85. (Pubitemid 20015129)
4. Blane, G.F. (1987): Comparative toxicity and safety profile of fenofibrate and other fibric acid derivatives. Am. J. Med., 83, 26-36.
5. Bomhard, E.M. (1996): Toxicology of glucosidase inhibitors. In Handbook of Experimental Pharmacology: Oral Antidiabetics, (Kuhlmann, J. and Puis, W.), pp.557-610, Springer Verlag, Berlin.
6. DeRosa, G. and Swick, R. W. (1975): Metabolic implications of the distribution of the alanine aminotransferase isoenzymes. J. Biol. Chem., 250, 7961-7967.
7. Edgar, A.D., Tomkiewicz, C., Costet, P., Legendre, C., Aggerbeck, M., Bouguet, J., Staels, B., Guyomard, C., Pineau, T. and Barouki, R. (1998): Fenofibrate modifies transaminase gene expression via a peroxisome proliferator activated receptor α-dependent pathway. Toxicol. Letters, 98, 13-23.
8. Elliott, B.M., Dodd, N.J.F. and Elcombe, C.R. (1986): Increased hydroxyl radical production in liver peroxisomal fractions from rats treated with peroxisome proliferators. Carcinogenesis, 7, 795-799.
9. Esbenshade, T.A., Kamanna V.S., Newman, H.A., Tortorella, V., Witiak, D.T. and Feller, D.R. (1990): In vivo and in vitro peroxisome proliferation properties of selected Clofibrate analogues in the rat. Structure-activity relationships. Biochem. Pharmacol., 40, 1263-1274.
10. Hoffmann, W.E., Kramer, J., Main, A.R. and Torres, L. (1989): Clinical enzymology. In The clinical chemistry of laboratory animals (eds. Loeb, W.F. and Quimby, F.W.), pp.239-242, Elsevier Science Ltd., Amsterdam.
11. Horio, Y., Tanaka, T., Taketoshi, M., Uno, T. and Wada, H. (1988): Rat cytosolic aspartate aminotransferase: regulation of its mRNA and contribution to gluconeogenesis. J. Biochem., 103, 805-808.
12. Katchman, B.J. and Zipf, R.E. (1970): Correlation between triglycerides and glutamic-pyruvic transaminase in men on high-fat diets. Clin. Chem., 16, 118-123.
13. Katsunuma, N., Okada, M. and Katsunuma, T. (1966): Different metabolic roles of transaminase isozymes. In Pyridoxal catalysis: enzymes and model systems (eds. Snell, E.E., Braunstein, A.E.), pp.255-268, John Wiley and Sons, New York.
14. Kornbrust, D.J., MacDonald, J.S., Peter, C.P., Duchai, D.M., Stubbs, R.J., Germershausen, J.I. and Alberts, A.W. (1989): Toxicity of the HMG-coenzyme A reductase inhibitor, lovastatin, to rabbits. J. Pharmacol. Exp. Ther., 248, 498-505.
15. Pedersen, PL., Greenawalt, J.W., Reynafarje, B., Hullihen, J., Decker, G.L., Soper, J.W. and Bustamante, E. (1978): Preparation and characterization of mitochondria and submitochondrial particles of rat liver and liver-derived tissues. Methods Cell Biol., 20, 411-481. (Pubitemid 9018527)
16. Ramaiah, SK. (2007): A toxicologist guide to the diagnostic interpretation of hepatic biochemical parameters. Food Chem. Toxicol., 45, 1551-1557.
17. Ramesh, B. and Pugalendi, K.V. (2005): Impact of umbelliferone on erythrocyte redox status in STZ-diabetic rats. Yale J. Biol. Med., 78, 133-140.
18. Rosen, F., Roberts, N.R. and Nichol, CA. (1959): Glucocorticosteroids and transaminase activity. I. Increased activity of glutamicpyruvic transaminase in four conditions associated with gluconeogenesis. J. Biol. Chem., 234, 476-480.
19. Schmidt, F.W. and Schmidt, E. (1989): Diagnostic application of mitochondrial enzymes and isoenzymes. Clin. Chim. Acta., 185, 253-263.
20. Thulin, P., Rafter, I., Stockling, K., Tomkiewicz, C, Norjavaara, E., Aggerbeck, M., Hellmold, H., Ehrenborg, E., Andersson, U., Cotgreave, I. and Glinghammar, B. (2008): PPARa regulates the hepatotoxic biomarker alanine aminotransferase (ALTl) gene expression in human hepatocytes. Toxicol. Appl. Pharmacol., 231, 1-9.
21. Tolman, K.G. (2000): Defining patient risks from expanded preventive therapies. Am. J. Cardiol., 85, 15E-19E.
22. Tomkiewicz, C., Muzeau, F., Edgar, A.D., Barouki, R. and Aggerbeck, M. (2004): Opposite regulation of the rat and human cytosolic aspartate aminotransferase genes by fibrates. Biochem. Pharmacol., 67, 213-225.
23. Watazu, Y., Uji, Y., Okabe, H., Shirahase, Y., Kaneda, N. and Kannen, A. (1993): Proteinase K inactivation of cytosolic aspartate aminotransferase isoenzyme for measurement of human serum mitochondrial aspartate aminotransferase. J. Clin. Lab. Anal., 7, 81-85.